Compare PHG & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHG | LII |
|---|---|---|
| Founded | 1891 | 1895 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.4B | 19.5B |
| IPO Year | N/A | 1999 |
| Metric | PHG | LII |
|---|---|---|
| Price | $30.93 | $551.64 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $595.92 |
| AVG Volume (30 Days) | ★ 1.2M | 465.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.71% | 0.94% |
| EPS Growth | N/A | ★ 1.11 |
| EPS | N/A | ★ 22.79 |
| Revenue | N/A | ★ $5,195,300,000.00 |
| Revenue This Year | $2.79 | $6.90 |
| Revenue Next Year | $4.38 | $5.69 |
| P/E Ratio | $28.46 | ★ $24.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.48 | $443.19 |
| 52 Week High | $33.44 | $689.44 |
| Indicator | PHG | LII |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 54.59 |
| Support Level | $30.73 | $535.21 |
| Resistance Level | $33.44 | $573.81 |
| Average True Range (ATR) | 0.46 | 19.16 |
| MACD | -0.15 | -1.20 |
| Stochastic Oscillator | 48.74 | 47.45 |
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Lennox International manufacturers and distributes heating, ventilating, air conditioning, and refrigeration products for the North American replacement (75% of sales) and new construction (25% of sales) markets. Residential HVAC (home comfort solutions) accounted for 67% of sales and commercial HVAC (building climate solutions) accounted for the remaining 33% of sales. To be clear, Lennox's commercial exposure is what its peers refer to as "residential and light commercial," lacks the scale and complexity of what is referred to as an "applied" solution. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand.